CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Dr Andrew Craig
Bernard and Francine Dorval Prize recipient in 2011
Although early in his career, Dr Andrew Craig’s research has already revealed new ways to stop the spread of cancer. He has made major contributions to understanding the underlying mechanism controlling cell migration and tissue invasion by cancer cells and tumour-associated immune cells.
Dr Craig’s lab studies a family of proteins that regulate cancer cell shape and promote their ability to move through tissue barriers. This process allows tumours to spread to other areas of the body, playing a significant factor in mortality rates. One of Dr Craig’s recent publications in Journal of Cell Science, an influential international cell biology publication, provided new insights into breast cancer cell invasion mechanisms and was featured on the cover of the May 2011 issue. Currently, the Craig lab is identifying and validating therapeutic targets in preclinical models of breast and lung cancer.
Dr Craig is an associate professor in the department of biomedical and molecular sciences at Queen’s University and is a member of cancer biology and genetics division of the Queen’s Cancer Research Institute. Dr Craig was previously supported by a Canadian Institutes of Health Research New Investigator award and his contributions to the field of cancer research have been outstanding in breadth, importance and distinction with over 1000 citations of his publications.